Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma-Reference-Cited by-同舟云学术

Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma

Published:2021 Issue:12 Volume:68 Page:1383-1390
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Ohmoto Akihiro¹,Shigematsu Yasuyuki²,Fukuda Naoki¹,Wang Xiaofei¹,Urasaki Tetsuya¹,Hayashi Naomi¹,Sato Yasuyoshi¹,Nakano Kenji¹,Yunokawa Mayu¹,Ono Makiko¹,Komai Yoshinobu³,Numao Noboru³,Yuasa Takeshi³,Yonese Junji³,Tomomatsu Junichi¹,Inamura Kentaro⁴,Takahashi Shunji¹

Affiliation:

1. Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan

2. Department of Pathology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan

3. Department of Genitourinary Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan

4. Division of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/68/12/68_EJ21-0277/_pdf

Reference26 articles.

1. 1 Kerkhofs TM, Verhoeven RH, Van der Zwan JM, Dieleman J, Kerstens MN, et al. (2013) Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur J Cancer 49: 2579–2586.

2. 2 Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30: 872–878.

3. 3 Lim JS, Lee SE, Kim JH, Kim JH (2020) Characteristics of adrenocortical carcinoma in South Korea: a registry-based nationwide survey. Endocr Connect 9: 519–529.

4. 4 Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, et al. (2009) Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27: 1250–1256.

5. 5 Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, et al. (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database. Eur J Endocrinol 166: 269–279.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current prospects of hereditary adrenal tumors: towards better clinical management;Hereditary Cancer in Clinical Practice;2024-03-26

2. Multiple drugs;Reactions Weekly;2023-07-01

3. Editorial Comment to Clinicopathological features of adrenal malignancies: Analysis of hospital‐based cancer registry data in Japan;International Journal of Urology;2022-08-24

4. Long‐term survival of a patient with refractory advanced adrenocortical carcinoma after combination chemotherapy with paclitaxel and carboplatin plus mitotane;IJU Case Reports;2022-04-30